Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 166 across all filing types
Latest filing 2024-01-31 Earnings Release
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
Earnings Release 2023
Earnings Release Classification · 1% confidence The document is titled "BOKSLUTSKOMMUNIKÉ JANUARI-DECEMBER 2023" (Year-End Report Communication January-December 2023) for MEDCAP AB (PUBL.). It contains detailed financial figures for the fourth quarter and the full twelve months (January-December 2023), including Net Sales, EBITDA, EBITA, and Earnings Per Share, presented in tables and narrative form. It also discusses financial goals and provides a summary of the year's performance. This structure, covering a full fiscal year with comprehensive financial results and management commentary, strongly indicates a full-year financial report. Since the document is extensive (over 82,000 characters) and presents the full results rather than just announcing them, it is classified as an Annual Report, which corresponds to the 10-K filing type in the US context, or the closest equivalent for comprehensive annual financial disclosure. Given the options, '10-K' is the most appropriate classification for a full-year financial report. FY 2023
2024-01-31 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is titled 'DELÅRSRAPPORT' (Interim Report) for the period 'JULI-SEPTEMBER 2023' for MedCap AB. It contains comprehensive financial statements, including income statements, cash flow data, balance sheet information, and management commentary on business performance for the third quarter and the first nine months of the year. It is a substantive financial report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report. 9M 2023
2023-10-27 Swedish
MedCap förvärvar Swedelift
M&A Activity Classification · 1% confidence The document is a press release dated October 26, 2023, announcing that MedCap, through its subsidiary Trident Industri AB, has acquired Swedelift AB. This transaction involves the purchase of a company, including details on the purchase price (cash, seller's note, and potential earn-out) and the strategic rationale. This type of announcement, concerning a merger or acquisition proposal/completion, directly corresponds to the definition for M&A Activity (TAR). It is not an earnings release (ER), a general regulatory filing (RNS), or a financing update (CAP), but a specific transaction announcement.
2023-10-26 Swedish
Valberedning i MedCap utsedd
AGM Information Classification · 1% confidence The document is a press release dated October 10, 2023, announcing the composition of the Nomination Committee (Valberedning) for the upcoming Annual General Meeting (AGM) in 2024. It details who appointed the members and outlines the committee's tasks, which include proposing board members and auditors for the AGM. This content directly relates to the governance structure and preparation for the AGM, specifically concerning the nomination process. While it mentions the AGM, it is not the AGM presentation itself (AGM-R) or the proxy materials (PSI). It is an announcement regarding the governance body responsible for nominations, which aligns best with Governance Information (CGR) or potentially a specific aspect of AGM preparation. Given the focus on the composition and mandate of the body responsible for nominating directors and setting fees, CGR (Governance Information) is the most appropriate fit, as it covers internal rules and board structure preparation. It is not a Director's Dealing (DIRS), Management change (MANG), or a general regulatory filing (RNS).
2023-10-10 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period April-June 2023 for MedCap. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on performance for the second quarter and the first half of the year. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report. Q2 2023
2023-07-28 Swedish
MedCap förvärvar SurgiCube och Toul Meditech
M&A Activity Classification · 1% confidence The document is a press release dated July 24, 2023, announcing that MedCap AB has signed an agreement to acquire SurgiCube International B.V. and Toul Meditech. It details the transaction terms (purchase price, earn-out) and includes quotes from the CEOs. The final paragraph explicitly states: "Denna information är sådan information som MedCap AB är skyldigt att offentliggöra enligt EU:s Marknadsmissbruksförordning." (This information is such information that MedCap AB is obliged to disclose pursuant to the EU's Market Abuse Regulation). This type of announcement, concerning a significant corporate transaction (M&A), is typically classified as a general regulatory announcement or a specific M&A filing. Since 'M&A Activity' (TAR) is defined for merger proposals or takeover bids, and this is a definitive acquisition announcement, TAR is the most appropriate specific category. It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Given the nature of the announcement under MAR, it fits best under M&A Activity (TAR).
2023-07-24 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.